| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/27/2008 | WO2008035069A1 Multimeric particles |
| 03/27/2008 | WO2008034866A2 Dbait and uses thereof |
| 03/27/2008 | WO2008034819A1 Injectable pharmaceutical nimesulide solutions |
| 03/27/2008 | WO2008034767A1 Cationic polymers as thickeners for aqueous and alcoholic compositions |
| 03/27/2008 | WO2008034391A1 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation |
| 03/27/2008 | WO2008017335A3 Starch silica co-precipitate, method for preparing the same and use thereof |
| 03/27/2008 | WO2008017334A3 Microemulsified drug formulation |
| 03/27/2008 | WO2008017277A3 Polymeric conjugates of doxorubicin with ph-regulated release of the drug and a method of preparing |
| 03/27/2008 | WO2008009831A3 Novel amphiphilic cyclodextrin derivatives |
| 03/27/2008 | WO2007133747A3 PULMONARY DELIVERY OF 1α,25-DIHYDROXYVITAMIN D3 AND CO-ADMINISTRATION OF PARATHYROID HORMONE OR CALCITONIN |
| 03/27/2008 | WO2007132296A3 Multilayer tablet |
| 03/27/2008 | WO2007119185A3 Degradable therapeutic delivery device |
| 03/27/2008 | WO2007080114A3 Macromolecule conjugate |
| 03/27/2008 | WO2007079082A3 Gastric release pulse system for drug delivery |
| 03/27/2008 | WO2007066151A3 Topical compositions for treatment of respiratory disorders |
| 03/27/2008 | WO2007053292A3 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
| 03/27/2008 | WO2007027371A3 Method of removing medical adhesive |
| 03/27/2008 | WO2006069133A3 Ionic drug-detergent complexes |
| 03/27/2008 | US20080076833 Phosphorylated Polyphenols as Colour-Stable Agents |
| 03/27/2008 | US20080076830 Pharmaceutical Composition in the Form of a Water Soluble Solid Dosage Form |
| 03/27/2008 | US20080076793 Use of an ascomycin for the treatment of blepharitis |
| 03/27/2008 | US20080076792 Heterobifunctional Polymeric Bioconjugates |
| 03/27/2008 | US20080076749 Stabilizing compositions for antibiotics and methods of use |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | US20080076710 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus |
| 03/27/2008 | US20080076704 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 03/27/2008 | US20080076703 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |
| 03/27/2008 | US20080075779 Additives And Methods For Enhancing Active Agent Elution Kinetics |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
| 03/27/2008 | US20080075768 Opioid antagonist is released to reduce effectiveness of opioid (hydromorphone) when dosage form is crushed; monolithic solidified oral dosage form; hydrophilic polymer such as alkyl cellulose or (meth)acrylic acid (co)polymer; drug delivery; resistant to dissolution in aqueous solutions of ethanol |
| 03/27/2008 | US20080075764 Synthetic and semi-synthetic three-dimensional bodies, such as liposomes, which antiinflammatory, organ protective and immune regulatory effects; autoimmune diseases |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075759 Edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin; consistent weight and texture; no heat or water required during manufacture; stability; drug delivery |
| 03/27/2008 | US20080075754 Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 03/27/2008 | US20080075747 Acidic oil in water emulsion comprising allantoin; emulsifier system of an acidic anionic polylmer such as carbopol and an ethoxylated ether or an ethoxylated ester; cosmetics; storage stability; can further include a carbohydrate polymer that can be polygalactose or polyarabinose |
| 03/27/2008 | US20080075731 nanoparticle comprising a core made of a metal or polyoxyethylene glycol coatings, binding to core with lipoprotein binding agent, 7-alpha hydroxylase or antibody, and nicotinamide adenine dinucleotide; drug delivery particles; using a magnet to administer nanoparticles to target anatomical site |
| 03/27/2008 | US20080075708 compounds having an anchoring domain that anchors the compound to the surface of target cell, and a therapeutic domain that can act extracellularly to prevent infection of the target cell by a pathogen, such as viruses; neuraminidase |
| 03/27/2008 | US20080073239 Injection-Molded Water Soluble Container |
| 03/27/2008 | CA2664339A1 Subunguicide, and method for treating onychomycosis |
| 03/27/2008 | CA2664109A1 Use of compositions comprising l-theanine and epigallocatechin gallate in the treatment and prevention of cold and/or influenza |
| 03/27/2008 | CA2664097A1 Edible water-soluble film containing a foam reducing flavoring agent |
| 03/27/2008 | CA2663062A1 Galenic form for the trans-mucosal delivery of active ingredients |
| 03/27/2008 | CA2662919A1 Pharmaceutical compositions containing rosuvastatin calcium |
| 03/27/2008 | CA2662065A1 Dbait and uses thereof |
| 03/27/2008 | CA2654726A1 Metallo-hydrolase inhibitors using metal binding moieties in combination with targeting moieties |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1902734A1 uPAR selective contrast agent for magnetic resonance imaging |
| 03/26/2008 | EP1902726A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 03/26/2008 | EP1902718A1 Active foam |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1902713A1 Pharmaceutical composition containing thiazolidinedione compound |
| 03/26/2008 | EP1902706A1 Stable pharmaceutical compositions of tetracyclines in solution, method for obtaining them and their uses |
| 03/26/2008 | EP1902705A1 Injectable pharmaceutical nimesulide solutions |
| 03/26/2008 | EP1901783A1 Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 03/26/2008 | EP1901778A2 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds |
| 03/26/2008 | EP1901777A2 Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau |
| 03/26/2008 | EP1901755A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 03/26/2008 | EP1901729A1 Pharmaceutical formulations of hdac inhibitors |
| 03/26/2008 | EP1901709A2 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent |
| 03/26/2008 | EP1901680A2 Methods and compositions for enhancing vascular access |
| 03/26/2008 | EP1747017B1 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 03/26/2008 | EP1620072B1 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 03/26/2008 | EP1592719B1 Conjugation reactions |
| 03/26/2008 | EP1536836B1 Topical emulsion- gel composition comprising diclofenac sodium |
| 03/26/2008 | EP1534072B1 Anthelmintic oral homogeneous veterinary pastes |
| 03/26/2008 | EP1490037B1 Taste masked veterinary solid compositions |
| 03/26/2008 | EP1423088B1 Stabilisation of oxidation-sensitive and uv-sensitive active ingredients |
| 03/26/2008 | EP1309330B1 Photosensitizers with ligand targeting properties for tumor therapy |
| 03/26/2008 | EP1187599B1 Stable benzimidazole formulation |
| 03/26/2008 | EP0781553B1 Patch for external use |
| 03/26/2008 | CN101151533A Procoagulants based on metal-chelating lipids |
| 03/26/2008 | CN101151054A Radiofluorinated peptides |
| 03/26/2008 | CN101151052A Layered nanoparticles |
| 03/26/2008 | CN101151048A Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/26/2008 | CN101151038A Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
| 03/26/2008 | CN101151028A Topical gels compositions |
| 03/26/2008 | CN101151025A Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 03/26/2008 | CN101150956A Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 03/26/2008 | CN101150955A Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 03/26/2008 | CN101148520A Temperature sensitive chitosan hydrogel |
| 03/26/2008 | CN101148483A Chitosan oligosaccharide-stearic acid grafting compound modified by folic acid, preparation method and application thereof |
| 03/26/2008 | CN101147806A Berberine intestinal controlled-releasing microcapsule and its preparation method |
| 03/26/2008 | CN101147805A Method for preparing magnetic silica medicine-carried microball in cotton seed oil by microemulsion liquid method |
| 03/26/2008 | CN101147800A Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method |
| 03/26/2008 | CN101147745A Artificial calculus bovis medicinal composition without smell of mutton, stench and bitter and preparation thereof |
| 03/26/2008 | CN101147744A Chitin water soluble aerosol and wound applied block composite medicine |
| 03/26/2008 | CN101147740A Medicinal composition for vagina and its preparation |
| 03/26/2008 | CN101147739A Composition containing rotigotine and its use and transdermal patch containing the composition |
| 03/26/2008 | CN101147735A Pharmaceutical composition for injection and its medicine box |
| 03/26/2008 | CN101147726A Good stability chloromycetin eyedrop and preparation method thereof |
| 03/26/2008 | CN101147725A Ketoconazole suppository composition for vaginal administration |
| 03/26/2008 | CN100376672C Alpha-isomaltosylglucosaccharide synthase, process for producing same and use thereof |
| 03/26/2008 | CN100376291C Porous drug matrices and methods of manufacturing the same |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376251C Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 03/26/2008 | CN100376232C Anaesthetic formulations |
| 03/25/2008 | US7348453 Complexing using an ortho carboxy acetal |
| 03/25/2008 | US7348364 Segmented copolyesters as compliant, absorbable coatings and sealants for vascular devices |
| 03/25/2008 | US7348360 Method and composition for delivering zinc to the nasal membrane |